Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicolas Vabret

Showing results (1-10 of 37) with videos related to

Pageof 4
Sort By:
Nature Reviews. Immunology|June 24, 2020
Preclinical data from SARS-CoV-2 mRNA vaccineNicolas Vabret
Nature Reviews. Immunology|July 21, 2020
Antibody responses to SARS-CoV-2 short-livedNicolas Vabret
The Journal of Experimental Medicine|April 9, 2021
Highlights from a year in a pandemicMiriam Merad, Nicolas Vabret
Nature Reviews. Immunology|November 11, 2025
Retroelements orchestrate gut toleranceLaura Rosenberg, Nicolas Vabret
Nature Reviews. Immunology|October 28, 2021
Repeat elements amplify TLR signalingTimothy O'Donnell, Nicolas Vabret
Nature Reviews. Immunology|April 15, 2020
Hydroxychloroquine: small effects in mild diseaseRachel Levantovsky, Nicolas Vabret
Nature Reviews. Immunology|January 12, 2024
Alternative RNA splicing generates shared clonal neoantigens across different types of cancerMatthew Brown, Nicolas Vabret
Trends in Cancer|September 23, 2025
Viral mimicry in cancer therapyLaura Rosenberg, Nicolas Vabret
Signal Transduction and Targeted Therapy|October 7, 2020
SARS-CoV-2: the many pros of targeting PLproChristopher B McClain, Nicolas Vabret
Frontiers in Immunology|January 9, 2014
Sensing microbial RNA in the cytosolNicolas Vabret, J Magarian Blander
Pageof 4

Showing results (1-10 of 37) with videos related to

Sort By:
Pageof 4
Nature Reviews. Immunology|June 24, 2020
Preclinical data from SARS-CoV-2 mRNA vaccineNicolas Vabret
Nature Reviews. Immunology|July 21, 2020
Antibody responses to SARS-CoV-2 short-livedNicolas Vabret
The Journal of Experimental Medicine|April 9, 2021
Highlights from a year in a pandemicMiriam Merad, Nicolas Vabret
Nature Reviews. Immunology|November 11, 2025
Retroelements orchestrate gut toleranceLaura Rosenberg, Nicolas Vabret
Nature Reviews. Immunology|October 28, 2021
Repeat elements amplify TLR signalingTimothy O'Donnell, Nicolas Vabret
Nature Reviews. Immunology|April 15, 2020
Hydroxychloroquine: small effects in mild diseaseRachel Levantovsky, Nicolas Vabret
Nature Reviews. Immunology|January 12, 2024
Alternative RNA splicing generates shared clonal neoantigens across different types of cancerMatthew Brown, Nicolas Vabret
Trends in Cancer|September 23, 2025
Viral mimicry in cancer therapyLaura Rosenberg, Nicolas Vabret
Signal Transduction and Targeted Therapy|October 7, 2020
SARS-CoV-2: the many pros of targeting PLproChristopher B McClain, Nicolas Vabret
Frontiers in Immunology|January 9, 2014
Sensing microbial RNA in the cytosolNicolas Vabret, J Magarian Blander
Pageof 4